EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy

Hongbin Wang, Mia Borlongan, Akseli Hemminki iD, Saru Basnet, Naresh Sah, Howard L Kaufman, Samuel D Rabkin iD, Dipongkor Saha iD

Human Gene Therapy · 2023

DOI: 10.1089/hum.2023.099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Gene Therapy, 2023. Verfasst von Hongbin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, California, USA. Hauptthemen laut MEDLINE: Oncolytic Virotherapy, Carcinoma, Renal Cell, Kidney Neoplasms, Oncolytic Viruses. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncolytic VirotherapyCarcinoma, Renal CellKidney NeoplasmsOncolytic VirusesAnimalsHumansInterleukin-2CytokinesImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

cancerimmunotherapyinterleukin 2local deliveryoncolytic virusproinflammatory cytokineviral vectorsvirotherapy

Substanzen

Interleukin-2Cytokines

Autor:innen und Institutionen

  • Department of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, California, USA.
  • Master of Pharmaceutical Sciences Program, College of Graduate Studies, California Northstate University, Elk Grove, California, USA.
  • Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • TILT Biotherapeutics Ltd., Helsinki, Finland.
  • Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Research Program Unit (RPU), University of Helsinki, Helsinki, Finland.

ORCID-Profile: Akseli Hemminki, Samuel D Rabkin, Dipongkor Saha

Förderung

  • NCI NIH HHS

Zitieren

APA

Wang, H., Borlongan, M., Hemminki, A., Basnet, S., Sah, N., Kaufman, H. L., Rabkin, S. D., & Saha, D. (2023). Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy. Human Gene Therapy. https://doi.org/10.1089/hum.2023.099

Vancouver

Wang H, Borlongan M, Hemminki A, Basnet S, Sah N, Kaufman HL, et al. Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy. Human Gene Therapy. 2023. doi:10.1089/hum.2023.099

BibTeX
@article{Wang2023,
  author = {Wang, Hongbin and Borlongan, Mia and Hemminki, Akseli and Basnet, Saru and Sah, Naresh and Kaufman, Howard L and Rabkin, Samuel D and Saha, Dipongkor},
  title = {Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy},
  journal = {Human Gene Therapy},
  year = {2023},
  doi = {10.1089/hum.2023.099}
}
Kostenlos starten →